Emergent BioSolutions, the Rockville biotech that sells the only approved anthrax vaccine to the federal government, has won a $220 million grant to establish a new biodefense development and manufacturing center in Maryland.
The Center for Innovation in Advanced Development and Manufacturing is designed to develop a range of medical countermeasures to biological, radiological and nuclear threats. It also will ensure the capability to produce vaccines for pandemic influenza and provide work force development programs for federal needs, according to a company statement.
To read the full, original article click on this link: Gazette.Net: Rockville biotech snags $220M for biodefense center
{iframe}http://www.gazette.net/article/20120618/NEWS/706189974/1033/rockville-biotech-snags-220m-for-biodefense-center&template=gazette{/iframe}